Dynamic contrast-enhanced MRI (DCE-MRI) and PET imaging studies have revealed elevated BBB permeability in cognitively normal individuals at risk for AD, especially ApoE4 carriers, as well as in patients with MCI and AD. This evidence concerns the gene APOE and Alzheimer disease.